Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.
Natalie Balanvosky
Advertisement
Natalie Balanvosky is just-in-time manufacturing solutions manager, Almac Clinical Services.
Articles by Natalie Balanvosky
Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.
Advertisement
Latest Updated Articles
Demystifying Complex Clinical Trial Kit PrepMay 15th 2021
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
3
BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial
4
Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors
5